CLARITY PHARMACEUTICALS LTD

Press Releases Clarity Pharmaceuticals Ltd

Equities

CU6

AU0000165375

Market Closed - Australian S.E. Other stock markets 02:10:52 2024-06-03 am EDT			5-day change	1st Jan Change
5.23 ^AUD	+2.95%		+17.26%	+175.26%

May. 30	Clarity Pharmaceuticals Signs Supply Deal for Copper Isotope	MT
Apr. 24	Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort	Nov. 30	AQ
Clarity and PSI kick off SAR-bisPSMA Phase III	23-10-27	AQ
Clarity Pharmaceuticals - First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial	23-10-04	AQ
Clarity Pharmaceuticals - First participant treated in the highest dose cohort of neuroblastoma trial	23-08-28	AQ
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial	23-08-28	AQ
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial	23-07-25	AQ
Clarity Pharmaceuticals - Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer	23-07-05	AQ
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics	23-06-29	AQ
Clarity commences COMBAT theranostic prostate cancer trial in the US	23-06-21	AQ
Clarity Pharmaceuticals : Application for quotation of securities - CU6	22-07-05	PU
Clarity Pharmaceuticals : Governance & Trading Policy Update	22-06-08	PU
Clarity Pharmaceuticals : Notification regarding unquoted securities - CU6	22-06-01	PU
Clarity Pharmaceuticals : Application for quotation of securities - CU6	22-04-21	PU
Clarity Pharmaceuticals : Application for quotation of securities - CU6	22-04-14	PU
Clarity Pharmaceuticals : - Investor Presentation 03-03-2022	22-03-02	PU
Clarity Pharmaceuticals : Half Yearly Report	22-02-28	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer